Britt W J, Chesebro B
J Exp Med. 1980 Dec 1;152(6):1795-804. doi: 10.1084/jem.152.6.1795.
H-2D (Rfv-1)-associated control of recovery from FV leukemia was studied in congenic mice. In irradiation chimeras, the high recovery phenotype was transferred by cells of the spleen, bone marrow, and fetal liver. Furthermore, in cell transfers using unirradiated recipients, spleen and bone marrow cells of the high-recovery genotype were able to mediate recovery from leukemia in mice of the low-recovery genotype. Thus, the H-2D (Rfv-1) influence on recovery appeared to operate via nonleukemic cells of the spleen and bone marrow rather than via leukemic cells. The specific nonleukemic cell type(s) involved in recovery remains unknown. However, the mechanism appears to be complex and probably involves both anti-FV antibody and FV-specific cytotoxic T lymphocytes.
在同源小鼠中研究了H-2D(Rfv-1)相关的从FV白血病恢复的调控。在辐射嵌合体中,高恢复表型由脾脏、骨髓和胎肝细胞转移。此外,在使用未受辐射受体的细胞转移中,高恢复基因型的脾脏和骨髓细胞能够介导低恢复基因型小鼠从白血病中恢复。因此,H-2D(Rfv-1)对恢复的影响似乎是通过脾脏和骨髓的非白血病细胞而非白血病细胞起作用。参与恢复的具体非白血病细胞类型尚不清楚。然而,其机制似乎很复杂,可能涉及抗FV抗体和FV特异性细胞毒性T淋巴细胞。